Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
T reg DLI for refractory chronic GVHD
NCT02749084Phase 2Completed
- Start
- Aug 2016
- Primary completion
- Dec 2021
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of regulatory T cells injection in chronic graft-versus-host disease (cGVHD). Started Aug 2016; status: completed.
02
Drugs
regulatory T cells injection
03
Conditions
chronic graft-versus-host disease (cGVHD)
Beyond the preview
Go deeper on NCT02749084.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02749084.